Navigation Links
Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference
Date:1/11/2010

PRINCETON, N.J., Jan. 11 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the 28th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2010 at 5:00 p.m. ET. Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

SOURCE Covance Inc.

RELATED LINKS
http://www.covance.com

'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
2. Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
3. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
4. Covance Receives Highest Level of Phase I Accreditation
5. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
6. Cell Therapeutics, Inc. (CTI) to Present at the 28th Annual JP Morgan Healthcare Conference
7. VirtualScopics to Present at the Upcoming OneMedPlace Investment Conference
8. Jazz Pharmaceuticals to Present at 2010 J.P. Morgan Healthcare Conference
9. Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
10. Inverness Medical Innovations to Present at the J.P. Morgan Healthcare Conference on January 12, 2010
11. Endo to Present at J.P. Morgan 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology:
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
Breaking Medicine News(10 mins):